相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons
Radhe Mohan et al.
NEURO-ONCOLOGY (2021)
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma
Sean McBride et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
Jiali Yu et al.
NATURE MEDICINE (2021)
A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma
Kevin X. Liu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platform 6-14)
Solange Peters et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer
John D. Fenwick et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients With Non-Small Cell Lung Cancer
Limei Yin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
FLASH-radiotherapy: A new perspective in immunotherapy era?
Melek Tugce Yilmaz et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Comparison of radiotherapy techniques with flattening filter and flattening filter-free in lung radiotherapy according to the treatment volume size
Alaettin Arslan et al.
SCIENTIFIC REPORTS (2020)
The future of radiation-induced abscopal response: beyond conventional radiotherapy approaches
Slavisa Tubin et al.
FUTURE ONCOLOGY (2020)
A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier cancer research network LUN 14-179
Greg A. Durm et al.
CANCER (2020)
Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 PembroRad randomized trial
J. Bourhis et al.
ANNALS OF ONCOLOGY (2020)
Radiotherapy-Related Lymphopenia Affects Overall Survival in Patients With Lung Cancer
Azadeh Abravan et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials
Willemijn S M E Theelen et al.
Lancet Respiratory Medicine (2020)
Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy
Zachary S. Buchwald et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
James Welsh et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio associations with heart and body dose and their effects on patient outcomes in locally advanced non-small cell lung cancer treated with definitive radiotherapy
Wu-Yan Xia et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study
T. Karantanos et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors
Luke R. G. Pike et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects
Slavisa Tubin et al.
RADIATION ONCOLOGY (2019)
Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?
Christine Menetrier-Caux et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Oxygen-enhanced MRI Is Feasible, Repeatable, and Detects Radiotherapy-induced Change in Hypoxia in Xenograft Models and in Patients with Non-small Cell Lung Cancer
Ahmed Salem et al.
CLINICAL CANCER RESEARCH (2019)
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
Daniel R. Gomez et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
David A. Palma et al.
LANCET (2019)
Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC
Qianqian Zhao et al.
RADIATION ONCOLOGY (2019)
Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy
Colton J. Ladbury et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy
Nuradh Joseph et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Clinical translation of FLASH radiotherapy: Why and how?
Jean Bourhis et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 Trial
Joshua M. Bauml et al.
JAMA ONCOLOGY (2019)
Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial
Willemijn S. M. E. Theelen et al.
JAMA ONCOLOGY (2019)
Radiation Induced Lymphopenia in NSCLC Patients Was Associated with Age, Lung V5, Smoking, and AA Genotype of XRCC1 rs25487 Assayed in Peripheral Lymphocytes
X. Xie et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy
Hari Menon et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Safety of stereotactic ablative body radiation for ultracentral stage I non-small cell lung cancer
Abraham J. G-Ching Wu
TRANSLATIONAL LUNG CANCER RESEARCH (2019)
Tumor-reprogrammed resident T cells resist radiation to control tumors
Ainhoa Arina et al.
NATURE COMMUNICATIONS (2019)
Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Respons
James W. Welsh et al.
CANCER IMMUNOLOGY RESEARCH (2019)
An Antitumor Immune Response Is Evoked by Partial-Volume Single-Dose Radiation in 2 Murine Models
Ela Markovsky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Time to abandon single-site irradiation for inducing abscopal effects
Eric D. Brooks et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Low-Dose Total Body Irradiation Can Enhance Systemic Immune Related Response Induced by Hypo-Fractionated Radiation
Jing Liu et al.
FRONTIERS IN IMMUNOLOGY (2019)
A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal Cancer
David M. Routman et al.
ADVANCES IN RADIATION ONCOLOGY (2019)
Radiation-related Lymphopenia after Pelvic Nodal Irradiation for Prostate Cancer
Michael D. Schad et al.
ADVANCES IN RADIATION ONCOLOGY (2019)
Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy
Alexander J. Lin et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Clinical and molecular features of innate and acquired resistance to anti-PD-1/PD-L1 therapy in lung cancer
Shalin Shah et al.
ONCOTARGET (2018)
PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation
Megan Morisada et al.
ONCOIMMUNOLOGY (2018)
Comparative analysis of the effect of different radiotherapy regimes on lymphocyte and its subpopulations in breast cancer patients
C. Yuan et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy
Ariel E. Marciscano et al.
CLINICAL CANCER RESEARCH (2018)
Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab
Richard W. Joseph et al.
CLINICAL CANCER RESEARCH (2018)
A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors
Bhanu Prasad Venkatesulu et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Total body irradiation in allogeneic bone marrow transplantation conditioning regimens: A review
Adrien Paix et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site
Heather M. McGee et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors
Jason J. Luke et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
Piet Ost et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma
Caroline Robert et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer
Jessika A. Contreras et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs
Julie M. Diamond et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer A Phase 2 Randomized Clinical Trial
Puneeth Iyengar et al.
JAMA ONCOLOGY (2018)
Cellular Composition and Contribution of Tertiary Lymphoid Structures to Tumor Immune Infiltration and Modulation by Radiation Therapy
Gael Boivin et al.
FRONTIERS IN ONCOLOGY (2018)
Hypofractionnated stereotactic radiotherapy and anti-PDL1 durvalumab combination in recurrent glioblastoma: Results of the phase I part of the phase I/II STERIMGLI trial.
Damien Pouessel et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Post-operative radiation effects on lymphopenia, neutrophil to lymphocyte ratio, and clinical outcomes in palatine tonsil cancers
Alexander J. Lin et al.
ORAL ONCOLOGY (2018)
In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
Matthew J. Frank et al.
CANCER DISCOVERY (2018)
Impact of curative radiotherapy on the immune status of patients with localized prostate cancer
Franziska Eckert et al.
ONCOIMMUNOLOGY (2018)
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
Silvia C. Formenti et al.
NATURE MEDICINE (2018)
Sensitivity of CD3/CD28-stimulated versus non-stimulated lymphocytes to ionizing radiation and genotoxic anticancer drugs: key role of ATM in the differential radiation response
Daniel Heylmann et al.
CELL DEATH & DISEASE (2018)
Spleen Dose-Volume Parameters as a Predictor of Treatment-related Lymphopenia During Definitive Chemoradiotherapy for Esophageal Cancer
Tetsuo Saito et al.
IN VIVO (2018)
Radiation effects on antitumor immune responses: current perspectives and challenges
Thomas Walle et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
Fernanda G. Herrera et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells
Chad Tang et al.
CLINICAL CANCER RESEARCH (2017)
The ADscopal Effect? Control of Partially Irradiated Versus Completely Irradiated Tumors on a Prospective Trial of Pembrolizumab and SBRT Per NRG-BR001
J. M. Lemons et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?
Awalpreet S. Chadha et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Higher Radiation Dose to Immune System is Correlated With Poorer Survival in Patients With Stage III Non-small Cell Lung Cancer: A Secondary Study of a Phase 3 Cooperative Group Trial (NRG Oncology RTOG 0617)
J. Y. Jin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial
Stephen G. Chun et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study)
Pierre Vera et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Alexander C. Huang et al.
NATURE (2017)
Dose-dependent enhancement of T-lymphocyte priming and CTL lysis following ionizing radiation in an engineered model of oral cancer
Megan Morisada et al.
ORAL ONCOLOGY (2017)
Effects of definitive and salvage radiotherapy on the distribution of lymphocyte subpopulations in prostate cancer patients
Eva K. Sage et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2017)
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille-Box et al.
NATURE COMMUNICATIONS (2017)
Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors
Adam Diehl et al.
ONCOTARGET (2017)
Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment
Yuki Muroyama et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Clinical Features of Acquired Resistance to Anti-PD-1 Therapy in Advanced Melanoma
Daniel Y. Wang et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Barriers to Radiation-induced In Situ Tumor vaccination
Erik Wennerberg et al.
FRONTIERS IN IMMUNOLOGY (2017)
Modeling the Cellular Response of Lung Cancer to Radiation Therapy for a Broad Range of Fractionation Schedules
Jeho Jeong et al.
CLINICAL CANCER RESEARCH (2017)
Dosimetric predictors of treatment-related lymphopenia induced by palliative radiotherapy: predictive ability of dose-volume parameters based on body surface contour
Tetsuo Saito et al.
RADIOLOGY AND ONCOLOGY (2017)
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
A. M. M. Eggermont et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial
Benjamin Movsas et al.
JAMA ONCOLOGY (2016)
Bayesian randomized trial comparing intensity modulated radiation therapy versus passively scattered proton therapy for locally advanced non-small cell lung cancer.
Zhongxing X. Liao et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
Jeffrey D. Bradley et al.
LANCET ONCOLOGY (2015)
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor et al.
NATURE (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8+ T cells
Joanne Y. H. Lim et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
Simon J. Dovedi et al.
CANCER RESEARCH (2014)
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Liufu Deng et al.
IMMUNITY (2014)
Lymphopenia Association With Gross Tumor Volume and Lung V5 and Its Effects on Non-Small Cell Lung Cancer Patient Outcomes
Chad Tang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice
Liufu Deng et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Histone Deacetylation Critically Determines T Cell Subset Radiosensitivity
Jason L. Pugh et al.
JOURNAL OF IMMUNOLOGY (2014)
Intensity-Modulated Radiotherapy for Lung Cancer: Current Status and Future Developments
Clara Chan et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
Eugene D. Kwon et al.
LANCET ONCOLOGY (2014)
Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice
Vincent Favaudon et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
Sofia R. Gameiro et al.
ONCOTARGET (2014)
Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
Encouse B. Golden et al.
ONCOIMMUNOLOGY (2014)
Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy
Felix Klug et al.
CANCER CELL (2013)
Treatment-related Lymphopenia in Patients With Stage III Non-Small-Cell Lung Cancer
Jian L. Campian et al.
CANCER INVESTIGATION (2013)
The Etiology of Treatment-related Lymphopenia in Patients with Malignant Gliomas: Modeling Radiation Dose to Circulating Lymphocytes Explains Clinical Observations and Suggests Methods of Modifying the Impact of Radiation on Immune Cells
Susannah Yovino et al.
CANCER INVESTIGATION (2013)
Hypoxia imaging using Positron Emission Tomography in non-small cell lung cancer: Implications for radiotherapy
Vikram Rao Bollineni et al.
CANCER TREATMENT REVIEWS (2012)
Long-Term Clinical Outcome of Intensity-Modulated Radiotherapy for Inoperable Non-Small Cell Lung Cancer: The MD Anderson Experience
Zhi-Qin Jiang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation
Anurag Gupta et al.
JOURNAL OF IMMUNOLOGY (2012)
Gating and tracking, 4D in thoracic tumours
D. Verellen et al.
CANCER RADIOTHERAPIE (2010)
Gamma-Ray Resistance of Regulatory CD4+CD25+Foxp3+ T Cells in Mice
Yanyan Qu et al.
RADIATION RESEARCH (2010)
Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer
Alessandra Battaglia et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody
M. Zahidunnabi Dewan et al.
CLINICAL CANCER RESEARCH (2009)
Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma
Claus Andrup Kristensen et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Anti-OX40 monoclonal antibody therapy in combination with radiotherapy results in therapeutic antitumor immunity to murine lung cancer
Hiroshi Yokouchi et al.
CANCER SCIENCE (2008)
Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells
Satoko Matsumura et al.
JOURNAL OF IMMUNOLOGY (2008)
Hypoxic radiosensitization: Adored and ignored
Jens Overgaard
JOURNAL OF CLINICAL ONCOLOGY (2007)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells
Monica V. Goldberg et al.
BLOOD (2007)
Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer
Robert Timmerman et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Eric A. Reits et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
S Gasser et al.
NATURE (2005)
Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphoma
J Honeychurch et al.
BLOOD (2003)
Long-term immune dysfunction after radiotherapy to the head and neck area
EL Verastegui et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy
M Chakraborty et al.
JOURNAL OF IMMUNOLOGY (2003)
Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo
JM Grayson et al.
JOURNAL OF IMMUNOLOGY (2002)
分享论文
